New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
BioNTech SE
BNTX
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

27B

Biotechnology

Next Earning date - 04 Nov 2024

27B

Biotechnology

Next Earning date - 04 Nov 2024

111.58USD
Shape-0.19 ( -0.17%)
favorite-chart

Relative Strenght

31
favorite-chart

Volume Buzz

-44%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

15%

Quote Panel

Shape
Updated October 22, 2024
1W -5.23 % 1M -1.30 % 3M 30.50 % 1Y 20.60 %

Key Metrics

Shape
  • Market Cap

    26.53B


  • Shares Outstanding

    237.73M


  • Share in Float

    237.11M


  • Dividende

    0


  • Earning Date

    04 Nov 2024


  • Price Target

    111.58


  • Average Volume

    975443


  • Beta

    0.245


  • Range

    76.53-131.49


  • Industry

    Biotechnology


  • Website

    https://www.biontech.de


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

8.93x

P/S Ratio

1.26x

P/B Ratio

0.0

Debt/Equity

-18.9%

Net Margin

$-2.3

EPS

How BNTX compares to sector?

P/E Ratio

Relative Strength

Shape

BNTX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$2B

Shape1792%

2025-Revenue

$2.52

Shape26%

2025-EPS

$372M

Shape157%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Morgan Stanley

upgrade

Previous: Equal-Weight

2024-09-23

Now: Overweight

Deutsche Bank

upgrade

Previous: Not converted

2024-08-06

Now: Buy

J.P. Morgan

downgrade

Previous: Not converted

2023-12-01

Now: Underweight

Citigroup

downgrade

Previous: Not converted

2023-12-01

Now: Underweight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-50%

7.13
vs 14.16

Q4.22

arrow
arrow

-25%

10.07
vs 13.47

Q1.23

arrow
arrow

-85%

2.24
vs 14.87

Q2.23

arrow
arrow

N/A

-0.86
vs 6.62

Q3.23

arrow
arrow

-90%

0.72
vs 7.13

Q4.23

arrow
arrow

-80%

2.06
vs 10.07

Q1.24

arrow
arrow

N/A

-1.42
vs 2.24

Q2.24

arrow
arrow

N/A

-3.62
vs -0.86

Q3.24

arrow
arrow

N/A

-1.55
vs 0.72

Q4.24

arrow
arrow

+68%

3.47
vs 2.06

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-43%

3.5B  vs 6.1B

Q4.22

arrow
arrow

-23%

4.3B  vs 5.5B

Q1.23

arrow
arrow

-80%

1.3B  vs 6.4B

Q2.23

arrow
arrow

-95%

167.7M  vs 3.2B

Q3.23

arrow
arrow

-74%

895.3M  vs 3.5B

Q4.23

arrow
arrow

-65%

1.5B  vs 4.3B

Q1.24

arrow
arrow

-85%

187.6M  vs 1.3B

Q2.24

arrow
arrow

-23%

129.4M  vs 167.7M

Q3.24

arrow
arrow

-30%

629.7M  vs 895.3M

Q4.24

arrow
arrow

+27%

1.9B  vs 1.5B

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+10%

0.1
vs 0.1

Q4.22

arrow
arrow

+11%

0.11
vs 0.1

Q1.23

arrow
arrow

+2%

0.02
vs 0.11

Q2.23

arrow
arrow

-1%

-0.01
vs 0.02

Q3.23

arrow
arrow

+1%

0.01
vs -0.01

Q4.23

arrow
arrow

+2%

0.02
vs 0.01

Q1.24

arrow
arrow

-2%

-0.02
vs 0.02

Q2.24

arrow
arrow

-4%

-0.04
vs -0.02

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

286

286
vs 315

-9%

Q4.22

arrow
arrow

348

348
vs 286

22%

Q1.23

arrow
arrow

304

304
vs 348

-13%

Q2.23

arrow
arrow

279

279
vs 304

-8%

Q3.23

arrow
arrow

282

282
vs 279

1%

Q4.23

arrow
arrow

311

311
vs 282

10%

Q1.24

arrow
arrow

314

314
vs 311

1%

Q2.24

arrow
arrow

310

310
vs 314

-1%

Earnings Growth

Latest News